peptide deformylase inhibitors (Pfizer)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namepeptide deformylase inhibitors (Pfizer)
Drug Alias NameMMP inhibitors (Pharmacia)PDF inhibitors (Pfizer)peptide deformylase inhibitors (Pharmacia)MMP inhibitors (Pfizer)PDF inhibitors (Pharmacia) +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase-2 inhibitorsMatrix metalloproteinase 13 inhibitorsPeptide deformylase inhibitors
TargetsMatrix metalloproteinase 13Matrix metalloproteinase-2Peptide deformylase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmacia Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer IncPharmacia Corp
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A